Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,674
New position
Shares Held
1,027
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#194
of 263 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 27%
Shared 0%
None 73%
Position in Biotechnology
Healthcare · as of Jun 30, 2026IFG Advisory, LLC holds $3,692,256 across 46 Biotechnology names. NVAX ranks #20 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
22,043 | $1,036,902 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,941 | $964,152 | |
| 3 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
5,039 | $491,201 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
1,447 | $412,351 | |
| 5 | MRNA |
Moderna, Inc.
|
3,925 | $274,867 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,678 | $212,338 | |
| 7 | INCY |
Incyte Corp
|
411 | $46,590 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
661 | $36,050 |
All Filings in NVAX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,674 | 1,027 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||